Bvf Partners L P Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Bvf Partners L P is Director of Kymera Therapeutics, Inc.. Currently has a direct ownership of 353,412 shares of KYMR, which is worth approximately $15.9 Million. The most recent transaction as insider was on Jun 30, 2025, when has been sold 317,167 shares (Common Stock, $0.0001 par value) at a price of $44.0 per share, resulting in proceeds of $13,955,348. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 353K
19.95% 3M change
19.95% 12M change
Total Value Held $15.9 Million

BVF PARTNERS L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
BUY
Open market or private purchase
$13,955,348 $44.0 p/Share
317,167 Added 47.3%
353,412 Common Stock, $0.0001 ...
Nov 03 2023
BUY
Open market or private purchase
$2,781,624 $14.07 p/Share
197,699 Added 40.16%
294,632 Common Stock, $0.0001 ...
Nov 02 2023
BUY
Open market or private purchase
$2,518,965 $11.64 p/Share
216,406 Added 43.2%
284,526 Common Stock, $0.0001 ...
Jan 12 2023
BUY
Open market or private purchase
$590,342 $31.24 p/Share
18,897 Added 0.99%
1,888,351 Common Stock, $0.0001 ...
Jan 11 2023
BUY
Open market or private purchase
$660,867 $29.89 p/Share
22,110 Added 1.17%
1,872,439 Common Stock, $0.0001 ...
Aug 22 2022
BUY
Open market or private purchase
$14,183,650 $26.0 p/Share
545,525 Added 67.91%
257,754 Common Stock, $0.0001 ...
May 27 2022
BUY
Open market or private purchase
$966,154 $14.78 p/Share
65,369 Added 22.08%
230,637 Common Stock, $0.0001 ...
May 26 2022
BUY
Open market or private purchase
$3,183,850 $14.21 p/Share
224,057 Added 49.63%
227,414 Common Stock, $0.0001 ...
May 20 2022
BUY
Open market or private purchase
$141,400 $14.0 p/Share
10,100 Added 4.45%
216,772 Common Stock, $0.0001 ...
May 06 2022
BUY
Open market or private purchase
$1,925,000 $19.25 p/Share
100,000 Added 31.57%
216,735 Common Stock, $0.0001 ...
May 05 2022
BUY
Open market or private purchase
$2,940,000 $19.6 p/Share
150,000 Added 41.37%
212,604 Common Stock, $0.0001 ...
Jan 31 2022
BUY
Open market or private purchase
$1,400,406 $40.7 p/Share
34,408 Added 2.41%
1,395,925 Common Stock, $0.0001 ...
Jan 27 2022
BUY
Open market or private purchase
$3,675,886 $38.33 p/Share
95,901 Added 6.49%
1,381,602 Common Stock, $0.0001 ...
Jan 24 2022
BUY
Open market or private purchase
$10,299,681 $37.76 p/Share
272,767 Added 16.87%
1,343,743 Common Stock, $0.0001 ...
Jul 01 2021
BUY
Open market or private purchase
$25,575,802 $47.0 p/Share
544,166 Added 72.29%
208,538 Common Stock, $0.0001 ...
Aug 21 2020
BUY
Grant, award, or other acquisition
$19,573,860 $20.0 p/Share
978,693 Added 84.39%
181,081 Common Stock, $0.0001 ...
Aug 21 2020
BUY
Conversion of derivative security
-
1,578,804 Added 93.3%
113,290 Common Stock, $0.0001 ...

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CTIC
CTI BIOPHARMA CORP Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
> 10% Shareholder
ARQL
ARQULE INC
> 10% Shareholder
SNDX
Syndax Pharmaceuticals Inc Healthcare
> 10% Shareholder
XOMA
XOMA Corp Healthcare
> 10% Shareholder
IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
> 10% Shareholder
FPRX
FIVE PRIME THERAPEUTICS, INC.
CALA
Calithera Biosciences, Inc. Healthcare
> 10% Shareholder
CYTK
CYTOKINETICS INC Healthcare
MRUS
Merus N.V. Healthcare
> 10% Shareholder
IDYA
IDEAYA Biosciences, Inc. Healthcare
PRNB
Principia Biopharma Inc.
> 10% Shareholder
OLMA
Olema Pharmaceuticals, Inc. Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
RAIN
Rain Therapeutics Inc. Healthcare
Director
RPTX
Repare Therapeutics Inc. Healthcare
> 10% Shareholder
CGEM
Cullinan Oncology, Inc. Healthcare
> 10% Shareholder
THRD
Third Harmonic Bio, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
> 10% Shareholder
MLTX
MoonLake Immunotherapeutics Healthcare
Director
PNT
POINT Biopharma Global Inc. Healthcare
FDMT
4D Molecular Therapeutics, Inc. Healthcare
ALLK
Allakos Inc. Healthcare
> 10% Shareholder
BPL

Bvf Partners L P

Director
San Francisco, CA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR